PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1833395
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1833395
North America Urology Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The North America Urology Devices Market was valued at USD 15.6 billion in 2024 and is estimated to grow at a CAGR of 7.1% to reach USD 30.9 billion by 2034.
An increasing number of patients are being diagnosed with conditions such as benign prostatic hyperplasia (BPH), urinary incontinence, kidney stones, and prostate cancer, creating sustained demand for advanced urology devices.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $15.6 Billion |
| Forecast Value | $30.9 Billion |
| CAGR | 7.1% |
Rising Demand for Products
The product segment held a notable share in 2024, driven by the availability of a broad range of specialized tools designed to diagnose and treat urological conditions with higher precision and less invasiveness. From endoscopes and drainage devices to laser systems and urodynamic equipment, product innovation remains at the core of market expansion. Increasing demand for technologically advanced devices that are integrated with AI or offering robotic-assisted functionalities is pushing manufacturers to focus on quality, safety, and performance.
Increasing Prevalence of Urolithiasis
The urolithiasis segment will grow at a decent CAGR during 2025-2034, fueled by the rising incidence of kidney stones and related urinary tract conditions across North America. Dietary habits, dehydration, and sedentary lifestyles are contributing to a growing patient pool requiring intervention for stone removal or management. This segment is benefiting from the shift toward minimally invasive techniques such as laser lithotripsy, ureteroscopy, and shock wave therapies. These methods reduce recovery time and hospital stays, making them highly preferred by both patients and healthcare providers.
Hospitals and Clinics to Gain Traction
The hospitals and clinics segment held a significant share in 2024 owing to their critical role in delivering specialized care and performing high-volume urological procedures. Hospitals are often the first point of care for patients with acute or complex urological conditions, which supports a high adoption rate of advanced diagnostic and therapeutic equipment. Clinics, on the other hand, are increasingly integrating outpatient surgical suits and specialized urology practices, expanding the reach of these devices beyond traditional inpatient settings.
U.S. to Emerge as a Propelling Region
U.S. urology devices market held a sizeable share in 2024, supported by a well-established healthcare system, strong R&D capabilities, and high awareness of urological health issues. Leading hospitals and ambulatory surgical centers across the U.S. are investing in state-of-the-art equipment to improve procedural accuracy and patient recovery outcomes.
Major players in the North America urology devices market are Cook Medical, Olympus Corporation, Teleflex, Ambu, Richard Wolf, Boston Scientific Corporation, NIPRO, Intuitive Surgical, Siemens Healthineers, B. Braun, Coloplast, and Laborie Medical Technologies.
To strengthen their foothold in the North America urology devices market, key companies are deploying a multi-pronged strategy centered on innovation, strategic partnerships, and regional expansion. Many are investing heavily in R&D to bring next-generation products to market-particularly devices that support minimally invasive procedures, enhance patient comfort, and integrate smart technology for real-time monitoring. Collaborations with healthcare providers and academic institutions help accelerate clinical validation and market acceptance.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Regional/country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product type trends
- 2.2.3 Application trends
- 2.2.4 End use trends
- 2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
- 2.4 Future outlook and strategic recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Value addition at each stage
- 3.1.3 Factor affecting the value chain
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising prevalence of urological disorders
- 3.2.1.2 Increasing awareness and early diagnosis
- 3.2.1.3 Technological advancements in therapeutic devices
- 3.2.1.4 Shift towards decentralized and home-based care
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Stringent regulatory hurdles
- 3.2.2.2 Limited access in rural areas
- 3.2.3 Market opportunities
- 3.2.3.1 Expansion of ambulatory and minimally invasive procedures
- 3.2.3.2 Increased demand for diagnostic tools
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Canada
- 3.5 Technological advancements
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
- 3.6 Supply chain analysis
- 3.7 Pricing analysis
- 3.8 Future market trends
- 3.9 Gap analysis
- 3.10 Porter's analysis
- 3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 North America
- 4.2.2 U.S.
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers and acquisitions
- 4.6.2 Partnerships and collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)
- 5.1 Key trends
- 5.2 Product
- 5.2.1 Endoscopes
- 5.2.1.1 Cystoscopes
- 5.2.1.1.1 Disposable
- 5.2.1.1.2 Reusable
- 5.2.1.2 Ureteroscopes
- 5.2.1.2.1 Disposable
- 5.2.1.2.2 Reusable
- 5.2.1.1 Cystoscopes
- 5.2.2 Laser and lithotripsy devices
- 5.2.3 Dialysis devices
- 5.2.4 Other products
- 5.2.1 Endoscopes
- 5.3 Accessories
- 5.3.1 Catheters
- 5.3.2 Stents
- 5.3.3 Lubricants and gels
- 5.3.4 Other accessories
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
- 6.1 Key trends
- 6.2 Urolithiasis
- 6.3 Urethral malignancies
- 6.4 Bladder disorders
- 6.5 Kidney diseases
- 6.6 Erectile dysfunction
- 6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals and clinics
- 7.3 Dialysis centers
- 7.4 Home care settings
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
- 8.1 Key trends
- 8.2 U.S.
- 8.3 Canada
Chapter 9 Company Profiles
- 9.1 Ambu
- 9.2 B. Braun
- 9.3 Boston Scientific Corporation
- 9.4 Coloplast
- 9.5 Cook Medical
- 9.6 Intuitive Surgical
- 9.7 Laborie Medical Technologies
- 9.8 NIPRO
- 9.9 Olympus Corporation
- 9.10 Richard Wolf
- 9.11 Siemens Healthineers
- 9.12 Teleflex
